SCHEMBL5844738

SCHEMBL5844738

Cc1cc(C)nc(CNc2ccc(NC(=O)C3CC(=O)N(c4ccccc4)C3)cc2)n1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.73
CA12 O43570 2/20 0.57
CA1 P00915 2/20 0.57
CA4 P22748 2/20 0.57
CA6 P23280 2/20 0.57
CA7 P43166 2/20 0.57
CA13 Q8N1Q1 2/20 0.57
CA2 P00918 1/20 0.57
CA9 Q16790 1/20 0.57
CA5B Q9Y2D0 1/20 0.57
MAPT P10636 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
GAA P10253 1/20 0.53
ROCK2 O75116 1/20 0.53
ROCK1 Q13464 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
LMNA P02545 1/20 0.52
TP53 P04637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5842946 0.92 ALDH1A1 (0.62) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL5842512 0.92 ALDH1A1 (0.62) ALDH1A1CA12CA1CA4CA6
SCHEMBL5843916 0.90 ALDH1A1 (0.71) ALDH1A1CA12CA1CA4CA6
SCHEMBL5842555 0.90 NPSR1 (0.61) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL5842314 0.89 SMN1; SMN2 (0.66) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL5841634 0.85 ALDH1A1 (0.55) ALDH1A1CA12CA1CA4CA6
SCHEMBL5842225 0.85 ALDH1A1 (0.77) ALDH1A1CA12CA1CA4CA6
SCHEMBL5841224 0.85 ALDH1A1 (0.67) ALDH1A1MAPTMEN1KMT2AL3MBTL1
SCHEMBL5844185 0.85 ALDH1A1 (0.54) ALDH1A1MAPTLMNA
SCHEMBL5843200 0.84 ALDH1A1 (0.53) ALDH1A1MAPTLMNATP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100534990-C Pyrrolidone carboxamides ACTELION PHARMACEUTICALS LTD (CH) 2009-09-02 CN disclosed
US-7067549-B2 Pyrrolidone carboxamides ACTELION PHARMACEUTICALS AG (CH) 2006-06-27 US disclosed
US-20050192292-A1 Pyrrolidone carboxamides ACTELION PHARMACEUTICALS AG (CH) 2005-09-01 US disclosed
CN-1610678-A Pyrrolidone carboxamides ACTELION PHARMACEUTICALS LTD (CH) 2005-04-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050192292-A1 Pyrrolidone carboxamides NPY1R, NPY5R, NPY2R ALDH1A1 3034/4885CA12 1561/4885CA1 1139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.